Sun Pharma to launch diabetes tablet in US

Sun Pharma to launch diabetes tablet in US

Chennai, Aug 2 (IANS) Indian drug major Sun Pharmacuetical Industries Ltd on Tuesday said it will launch the generic version of Glumetza, Metformin Hydrochloride tablets – a diabetes drug – soon in the US.

The company said in a statement, that one of its subsidiaries got the final approval from the US Food and Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for generic version of Glumetza, Metformin Hydrochloride extended release tablets 500 mg and 1,000 mg.

“These Metformin Hydrochloride extended release tablets are therapeutic equivalents of Santarus Inc’s Glumetza tablets,” the statement said.

The tablets may have an annual sales of around $1.2 billion in the US, the company added.

Leave a Reply

Please enter your comment!

The opinions, views, and thoughts expressed by the readers and those providing comments are theirs alone and do not reflect the opinions of www.mangalorean.com or any employee thereof. www.mangalorean.com is not responsible for the accuracy of any of the information supplied by the readers. Responsibility for the content of comments belongs to the commenter alone.  

We request the readers to refrain from posting defamatory, inflammatory comments and not indulge in personal attacks. However, it is obligatory on the part of www.mangalorean.com to provide the IP address and other details of senders of such comments to the concerned authorities upon their request.

Hence we request all our readers to help us to delete comments that do not follow these guidelines by informing us at  info@mangalorean.com. Lets work together to keep the comments clean and worthful, thereby make a difference in the community.

Please enter your name here